Reviva Pharmaceuticals
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
EBITDA | -6,040 | -6,416 | ||
Net Income | -6,053 | -6,432 | -6,259 | -8,365 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -5,012 | -8,194 | -9,100 | -4,241 |
Cash | 10,363 | 5,289 | 13,476 | 5,558 |
Basic Shares | 49,847 | 48,644 | 46,579 | 33,804 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
EBITDA | -29,880 | -39,503 | -24,111 | -8,513 |
EBIT | -24,306 | -10,104 | ||
Net Income | -29,918 | -39,260 | -24,339 | -8,521 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -33,543 | -28,324 | -18,960 | -10,668 |
Cash | 13,476 | 23,367 | 18,519 | 29,687 |
Basic Shares | 33,147 | 23,798 | 19,516 | 14,790 |
